Viktoriya Boncheva

Dr. Viktoriya Boncheva

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
VBViktoriya Boncheva
Viktoriya Boncheva
MLMichael Linnebacher
Michael Linnebacher
SKSaid Kdimati
Said Kdimati
HDHannah Draper
Hannah Draper
LOLaurence Orchard
Laurence Orchard
Barbara-ann GuinnBarbara-ann Guinn
Barbara-ann Guinn
A Crohn’s-like lymphoid reaction (CLR) is observed in about 15% of colorectal cancer (CRC) patients and is associated with favourable outcomes. To identify the immune targets recognised by CRC CLR patient sera, we immunoscreened a testes cDNA library with sera from three patients. Immunoscreening of the 18 antigens identified by SEREX with sera from normal donors showed that only the heavy chain of IgG3 (IGHG3) and a novel antigen we named UOB-COL-7, were solely recognised by sera from CRC CLR patients. ELISA showed an elevation in IgG3 levels in patients with CRC (p = 0.01). To extend our studies we analysed the expression of our SEREX-identified antigens using the RNA-sequencing dataset (GSE5206). We found that the transcript levels of multiple IGHG probesets were highly significant (p < 0.001) in their association with clinical features of CRC while above median levels of DAPK1 (p = 0.005) and below median levels of GTF2H5 (p = 0.004) and SH3RF2 (p = 0.02) were associated with improved overall survival. Our findings demonstrate the potential of SEREX-identified CRC CLR antigens to act as biomarkers for CRC and provide a rationale for their further characterization and validation.

17 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
EMEithar Mohamed
Eithar Mohamed
SGSara Goodman
Sara Goodman
LCLeah Cooksey
Leah Cooksey
DFDaniel Maxim Fletcher
Daniel Maxim Fletcher
VBViktoriya Boncheva
Viktoriya Boncheva
Barbara-ann GuinnBarbara-ann Guinn
Barbara-ann Guinn
Background: Adult B-cell acute lymphoblastic leukaemia (aB-ALL) is characterised by abnormal differentiation and proliferation of lymphoid progenitors. Despite a significant improvement in relapse-free and overall survival for children with B-ALL, aB-ALL has a particularly poor prognosis with a 5-year survival rate of 20%. First remission is achieved for most patients but relapse is common with a high associated mortality. New treatments such as immunotherapy offer an opportunity to extend remission and prevent relapse. Methods: aB-ALL antigens were identified using different sources - immunoscreening, protoarrays, two microarrays and one cancer-testis antigen (CTA) database, and a review of the genomic analyses of aB-ALL. 385 aB-ALL-associated gene products were examined for their association with patient survival. Results: We identified 87 transcripts with differential expression between aB-ALL and healthy donors, and 42 that were associated with survival. Enrichr analysis showed that the Transforming Growth Factor-β (TGFβ), Wnt and hippo pathways were highly represented (p<0.02). We found that SOX4 was upregulated in all types of B-ALL, while ROCK1 was upregulated in all types of B-ALL (p<0.001 except t(8;14)) and along with SMAD3 and TEAD4 were associated with survival (p=0.0008, 0.05 and 0.001 respectively). Expression of each aB-ALL antigen was verified by qPCR but only TEAD4 showed significant transcript upregulation in aB-ALL compared to healthy donor CD19+ cells (p=0.01). Conclusions: We have identified a number of antigens and their pathways that play key roles in aB-ALL and may act as useful targets for future immunotherapy strategies.

13 December 2024 in Urology Case Reports
Verified
Journal Article
Open access
VBViktoriya Boncheva
Viktoriya Boncheva
OYOmid Yassaie
Omid Yassaie
AKAndrew Kennedy-Smith
Andrew Kennedy-Smith
Primary malignant mucosal melanoma of the female urethra is extremely rare and associated with high recurrence rates and exceptionally poor 5-year survival. Due to its rarity, treatment strategies are heterogenous and often extrapolated from the treatment of other more common types of melanomas. Herein, we describe a case of malignant melanoma of the urethra in a Caucasian female.

22 April 2025 in Onco
Verified
Journal Article
Open access
PDF file
EMEithar Mohamed
Eithar Mohamed
SGSara Goodman
Sara Goodman
LCLeah Cooksey
Leah Cooksey
DFDaniel Maxim Fletcher
Daniel Maxim Fletcher
ODOlivia Dean
Olivia Dean
Barbara-ann GuinnBarbara-ann Guinn
Barbara-ann Guinn
Background: Adult B-cell acute lymphoblastic leukaemia (aB-ALL) is characterised by abnormal differentiation and proliferation of lymphoid progenitors. Despite a significant improvement in relapse-free and overall survival for children with B-ALL, aB-ALL has a particularly poor prognosis with a 5-year survival rate of 20%. First remission is achieved for most patients, but relapse is common with a high associated mortality. New treatments such as immunotherapy offer an opportunity to extend remission and prevent relapse. Methods: aB-ALL antigens were identified using different sources—immunoscreening, protoarrays, two microarrays and one cancer-testis antigen database, and a review of the genomic analyses of aB-ALL. A total of 385 aB-ALL-associated gene products were examined for their association with patient survival. Results: We identified 87 transcripts with differential expression between aB-ALL and healthy volunteers (peripheral blood, bone marrow and purified CD19+ cells), and 42 that were associated with survival. Enrichr analysis showed that the Transforming Growth Factor-β (TGFβ), Wnt and Hippo pathways were highly represented (p < 0.02). We found that SOX4 and ROCK1 were upregulated in all types of B-ALL (ROCK1 having a p < 0.001 except in t(8;14) patients), as well as SMAD3 and TEAD4 upregulation being associated with survival (p = 0.0008, 0.05 and 0.001, respectively). Expression of each aB-ALL antigen was verified by qPCR, but only TEAD4 showed significant transcript upregulation in aB-ALL compared to healthy volunteer CD19+ cells (p = 0.01). Conclusions: We have identified a number of antigens and their pathways that play key roles in aB-ALL and may act as useful targets for future immunotherapy strategies.

18 August 2025 in Urology Case Reports
Verified
Journal Article
Open access
VBViktoriya Boncheva
Viktoriya Boncheva
KMKatie Mallalieu
Katie Mallalieu
OYOmid Yassaie
Omid Yassaie
Bladder wall abscesses are rare and present a diagnostic challenge, particularly in high-risk patients. We report the first known case of a bladder wall abscess in an adult female with a neurogenic bladder using clean intermittent self-catheterisation (CISC), ultimately diagnosed with squamous cell carcinoma (SCC) of the bladder. Infective symptoms and imaging consistent with abscess delayed the diagnosis of moderately differentiated SCC. This case highlights the diagnostic difficulty of bladder abscesses and the importance of early histological evaluation in atypical or non-resolving lesions. Malignancy should always be considered in high-risk individuals with neurogenic bladder and long-term CISC.